Digital therapeutics have become a critical part of healthcare today, as individuals continue to demand more accessible, convenient, and affordable care options. With the US digital therapeutics market valued at $1.8B in 2022 and expected to rise to $10.3B by 2030, more employers are looking to add digital therapeutics to their benefit design to proactively manage high-cost claims and provide preventative care.

Offering a digital musculoskeletal (MSK) solution empowers employees to participate in their own health and well-being, when and where it is most convenient for them, ultimately leading to higher engagement than traditional care options. Digital therapeutics also allow for a more personalized treatment plan that is adjusted based on real-time data and feedback, resulting in better outcomes. But how can technology successfully coincide with traditional in-person care and telehealth? Join Ken Barlotta, VP of Employer Sales, Simon Hayhurst, Chief Product Officer, and Jodie McGinlay PT, DPT to learn about the benefits of technology and AI in MSK care and how it can successfully complement physical therapist’s work while also improving the patient experience, clinical outcomes, and financial benefits for employers and their employees.